Table 3.
Co-Expression of CD8 and Fox3p with PD-L1 and IDO (N=112)
| PD-L1 Tumor Staining | p-value | PD-L1 Immune Staining | p-value | IDO Tumor Staining | p-value | IDO Immune Staining | p-value | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|||||||||
| Negative | Positive | Negative | Positive | Negative | Positive | Negative | Positive | |||||
|
|
|
|
|
|||||||||
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |||||
| CD8 | ||||||||||||
| Low (<12.95) | 45 (56) | 11 (34) | 0.04 | 23 (77) | 33 (40) | 0.0006 | 30 (64) | 26 (40) | 0.01 | 35 (69) | 21 (34) | 0.0003 |
| High (≥12.95) | 35 (44) | 21 (66) | 7 (23) | 49 (60) | 17 (36) | 39 (60) | 16 (31) | 40 (66) | ||||
| Fox3p | ||||||||||||
| Low (<3.2) | 44 (55) | 12 (38) | 0.09 | 21 (70) | 35 (43) | 0.01 | 28 (60) | 28 (43) | 0.08 | 30 (59) | 26 (43) | 0.09 |
| High (≥3.2) | 36 (45) | 20 (63) | 9 (30) | 47 (57) | 19 (40) | 37 (57) | 21 (41) | 35 (57) | ||||